Sofia Angels Ventures has invested €2 million in Blue Longevity Clinic, a pioneering health company focused on preventive care and longevity, set to launch clinics in Athens, Sofia, and Istanbul by September 2025.
Information on the Target
Sofia Angels Ventures (SAV) is pleased to announce its participation in a €2 million seed funding round for Blue Longevity Clinic, an innovative longevity and preventive health company. Set to launch clinics in Athens, Sofia, and Istanbul by September 2025, the clinic aims to extend healthspan—the duration of years lived in good health—through an integrated approach that combines advanced diagnostics, evidence-based therapies, and proprietary digital tools. Founded by experienced healthcare entrepreneur Ilian Grigorov, who is known for his work at City Clinic and Blocks Health, Blue Longevity Clinic endeavors to revolutionize healthcare by shifting the focus from merely treating symptoms to delaying and potentially reversing age-related decline.
Industry Overview in Southeast Europe
The healthcare landscape in Southeast Europe is undergoing significant transformation. With one of the fastest-growing out-of-pocket healthcare markets in the European Union, there is a burgeoning demand for preventive healthcare solutions. As populations age, the emphasis on effective healthcare systems is shifting from reactive to proactive models that prioritize longevity and well-being.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
This rise in demand is driven by increasing awareness of personalized medicine and preventive care, providing a promising environment for innovative health services such as Bl
Similar Deals
Kurma Partners, WE Life Sciences, Bpifrance, Argobio, Angelini Ventures, CARMA Fund, Capital Grand Est, Sambrinvest → Elkedonia
2025
SC Launch Inc. → NeuroQuest
2025
Sofia Angels Ventures
invested in
Blue Longevity Clinic
in 2025
in a Seed Stage deal
Disclosed details
Transaction Size: $2M